Next Article in Journal
Association of Polymorphisms in the Glutathione S-Transferase Theta-1 Gene with Cirrhosis and Hepatocellular Carcinoma in Brazilian Patients with Chronic Hepatitis C
Next Article in Special Issue
CoV-RBD121-NP Vaccine Candidate Protects against Symptomatic Disease following SARS-CoV-2 Challenge in K18-hACE2 Mice and Induces Protective Responses That Prevent COVID-19-Associated Immunopathology
Previous Article in Journal
Rabbit Monoclonal Antibody Specifically Recognizing a Linear Epitope in the RBD of SARS-CoV-2 Spike Protein
Previous Article in Special Issue
Microparticles and Nanoparticles from Plants—The Benefits of Bioencapsulation
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Vaccines
Volume 9
Issue 8
10.3390/vaccines9080830
vaccines-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Frontiers in Bioengineering and Biotechnology: Plant Nanoparticles for Anti-Cancer Therapy

by
Erum Shoeb
1,2,
Uzma Badar
1,2,
Srividhya Venkataraman
1 and
Kathleen Hefferon
1,*
1
Department of Cell and Systems Biology, University of Toronto, Toronto, ON M5S 1A1, Canada
2
Department of Genetics, University of Karachi, Karachi 75270, Pakistan
*
Author to whom correspondence should be addressed.
Vaccines 2021, 9(8), 830; https://doi.org/10.3390/vaccines9080830
Submission received: 11 May 2021 / Revised: 9 July 2021 / Accepted: 9 July 2021 / Published: 28 July 2021
(This article belongs to the Special Issue Plant Based Vaccines- A Powerhouse for Global Health)
Browse Figures
Review Reports Versions Notes

Abstract

Naturally occurring viral nanomaterials have gained popularity owing to their biocompatible and biodegradable nature. Plant virus nanoparticles (VNPs) can be used as nanocarriers for a number of biomedical applications. Plant VNPs are inexpensive to produce, safe to administer and efficacious as treatments. The following review describes how plant virus architecture facilitates the use of VNPs for imaging and a variety of therapeutic applications, with particular emphasis on cancer. Examples of plant viruses which have been engineered to carry drugs and diagnostic agents for specific types of cancer are provided. The drug delivery system in response to the internal conditions is known as stimuli response, recently becoming more applicable using plant viruses based VNPs. The review concludes with a perspective of the future of plant VNPs and plant virus-like particles (VLPs) in cancer research and therapy.
Keywords: nanoparticles; plant virus-like particles; therapeutics; imaging; cancer nanoparticles; plant virus-like particles; therapeutics; imaging; cancer

Share and Cite

MDPI and ACS Style

Shoeb, E.; Badar, U.; Venkataraman, S.; Hefferon, K. Frontiers in Bioengineering and Biotechnology: Plant Nanoparticles for Anti-Cancer Therapy. Vaccines 2021, 9, 830. https://doi.org/10.3390/vaccines9080830

AMA Style

Shoeb E, Badar U, Venkataraman S, Hefferon K. Frontiers in Bioengineering and Biotechnology: Plant Nanoparticles for Anti-Cancer Therapy. Vaccines. 2021; 9(8):830. https://doi.org/10.3390/vaccines9080830

Chicago/Turabian Style

Shoeb, Erum, Uzma Badar, Srividhya Venkataraman, and Kathleen Hefferon. 2021. "Frontiers in Bioengineering and Biotechnology: Plant Nanoparticles for Anti-Cancer Therapy" Vaccines 9, no. 8: 830. https://doi.org/10.3390/vaccines9080830

APA Style

Shoeb, E., Badar, U., Venkataraman, S., & Hefferon, K. (2021). Frontiers in Bioengineering and Biotechnology: Plant Nanoparticles for Anti-Cancer Therapy. Vaccines, 9(8), 830. https://doi.org/10.3390/vaccines9080830

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop